Gadupudi Ramakrishna

Title: Gadupudi Ramakrishna: Innovator in Anti-Tubercular and Anti-Cancer Research

Introduction

Gadupudi Ramakrishna is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the fields of medicinal chemistry and pharmacology. With a focus on developing innovative compounds, he has been instrumental in advancing research aimed at combating serious health issues.

Latest Patents

Gadupudi Ramakrishna holds 3 patents that showcase his expertise in creating novel therapeutic agents. His latest patents include:

1. **Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents** - This invention provides nitrofurfuryl substituted phenyl linked piperidino-oxadiazolone compounds of general formula (A) as anti-tubercular agents. The compounds are characterized by specific substituents that enhance their efficacy against tuberculosis.

2. **Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof** - This patent presents a compound of general formula A, which is useful as potential anticancer agents against eleven human cancer cell lines. The invention also details a process for preparing diaryl ether linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

Career Highlights

Gadupudi Ramakrishna is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work is characterized by a commitment to developing innovative solutions to pressing health challenges.

Collaborations

He has collaborated with notable colleagues, including Arutla Viswanath and Ahmed Kamal, to further enhance the impact of his research.

Conclusion

Gadupudi Ramakrishna's contributions to the fields of anti-tubercular and anti-cancer research highlight his role as a leading inventor. His innovative patents reflect a dedication to improving health outcomes through scientific advancement.